Skip to main content
Advertisement
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
ADVERTISEMENT
Josep Llovet
O-021: Ramucirumab in Advanced Hepatocellular Carcinoma and Elevated Alpha-fetoprotein Following Sorafenib: Outcomes by Prior Transarterial Chemoembolisation From Two Randomised, Double-blind, Placebo-controlled Phase 3 Studies (REACH-2 and REACH)
Access the abstract
Yoon-Koo Kang , MD, PhD;
Chia-Jui Yen ;
Peter R. Galle , MD, PhD;
Josep Llovet ;
Eric Assenat ;
Giovanni Brandi ;
Kenta Motomura ;
Takuji Okusaka ;
Mark Karwal ;
Ari Baron ;
Masafumi Ikeda ;
Kun Liang ;
Richard A. Hubner ;
Chunxiao Wang ;
Masatoshi Kudo , MD, PhD;
Ryan Widau ;
Tim Meyer ;
William Schelman ;
Richard S. Finn ;
Andrew Zhu ;
07/31/2019
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Advertisement
Advertisement
Advertisement
Advertisement
Upcoming Events
November 6 – November 8
November 7 – November 10
November 8 – November 10
November 8
November 13 – November 16
November 14 – November 15
November 23 – November 24
December 4 – December 5
December 6 – December 7
December 9 – December 11
See Full Calendar
Advertisement
Advertisement
Advertisement